Pricing Log in Create free account

Curis, Inc. (CRIS) vs Kiora Pharmaceuticals, Inc. (KPRX)

Curis, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Kiora Pharmaceuticals, Inc. is the larger, with a market value of $6.6M against $5.7M — 1.2× the size. Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −13.4%. Across the 15 metrics below, Curis, Inc. leads on 8 and Kiora Pharmaceuticals, Inc. on 7.

Valuation

Metric CRIS KPRX Biotechnology median
P/E n/m n/m 10.26
P/S 0.20 0.49 9.18
P/B 0.40 0.55 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.29 0.59 0.65
EV/Sales (0.27) (0.40) 8.98
Earnings yield (1,634.48%) (166.02%) (34.89%)
Free cash flow yield (1,668.41%) (93.58%) (24.52%)

Profitability

Metric CRIS KPRX Biotechnology median
Gross margin 99.52% 85.06% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (56.36%) (50.12%)
Return on assets (87.76%) (39.43%) (45.60%)
Return on invested capital 0.00% (44,053.91%) 0.00%

Growth

Metric CRIS KPRX Biotechnology median
Revenue growth (TTM) (13.43%) 983.73% 6.26%
EPS growth (last fiscal year) 91.57% (403.45%) 29.88%
Revenue growth, 5-year CAGR (2.71%) 88.72% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 8.97 4.89
Net debt to EBITDA 0.91 1.33 1.01

Dividend

Metric CRIS KPRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRIS KPRX Biotechnology median
Market cap 5.67m 6.63m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack